FDA provides summaries of adverse drug experiences

被引:0
|
作者
不详
机构
关键词
D O I
暂无
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
引用
收藏
页码:685 / 685
页数:1
相关论文
共 50 条
  • [21] Combining Social Media and FDA Adverse Event Reporting System to Detect Adverse Drug Reactions
    Ying Li
    Antonio Jimeno Yepes
    Cao Xiao
    Drug Safety, 2020, 43 : 893 - 903
  • [22] SEDATION DISASTERS - ADVERSE DRUG REPORTS IN PEDIATRICS - FDA, UPS, AND OTHERS
    COTE, CJ
    ALDERFER, RJ
    NOTTERMAN, DA
    FANTA, KB
    ANESTHESIOLOGY, 1995, 83 (3A) : A1183 - A1183
  • [23] Detecting adverse drug reactions in discharge summaries of electronic medical records using Readpeer
    Tang, Yixuan
    Yang, Jisong
    Ang, Pei San
    Dorajoo, Sreemanee Raaj
    Foo, Belinda
    Soh, Sally
    Tan, Stew Har
    Tham, Mun Yee
    Ye, Qing
    Shek, Lynette
    Sung, Cynthia
    Tung, Anthony
    INTERNATIONAL JOURNAL OF MEDICAL INFORMATICS, 2019, 128 : 62 - 70
  • [24] Biclustering of Adverse Drug Events in the FDA's Spontaneous Reporting System
    Harpaz, R.
    Perez, H.
    Chase, H. S.
    Rabadan, R.
    Hripcsak, G.
    Friedman, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 (02) : 243 - 250
  • [25] The FDA Drug Safety Surveillance Program: Adverse Event Reporting Trends
    Weiss-Smith, Sheila
    Deshpande, Gaurav
    Chung, Stephanie
    Gogolak, Victor
    ARCHIVES OF INTERNAL MEDICINE, 2011, 171 (06) : 591 - 593
  • [26] FDA warns of adverse events linked to smoking cessation drug and antiepileptics
    Kuehn, Bridget M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2008, 299 (10): : 1121 - 1122
  • [27] POST-MARKETING SURVEILLANCE OF ADVERSE DRUG EXPERIENCES
    CAPPUCCI, DR
    TURNER, NJ
    KLINCK, PC
    BEAULIEU, AJ
    GRAVES, WL
    JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1981, 179 (03) : 264 - 264
  • [28] A PHARMACEUTICAL MANUFACTURERS PERSPECTIVE ON REPORTING ADVERSE DRUG EXPERIENCES
    SULLIVAN, JW
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1990, 47 (06): : 1342 - 1345
  • [29] IFT provides answers for FDA
    Snowdon, JA
    FOOD TECHNOLOGY, 2001, 55 (03) : 22 - 22
  • [30] A systematic comparison of hepatobiliary adverse drug reactions in FDA and EMA drug labeling reveals discrepancies
    Wu, Yue
    Xiao, Wenzhong
    Tong, Weida
    Borlak, Juergen
    Chen, Minjun
    DRUG DISCOVERY TODAY, 2022, 27 (01) : 337 - 346